Phreesia (NYSE:PHR) Insider Sells $102,544.48 in Stock

Phreesia, Inc. (NYSE:PHR) insider Evan Roberts sold 6,268 shares of Phreesia stock in a transaction on Friday, January 16th. The stock was sold at an average price of $16.36, for a total value of $102,544.48. Following the transaction, the insider directly owned 826,554 shares of the company’s stock, valued at $13,522,423.44. This trade represents a 0.75% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Evan Roberts also recently made the following trade(s):

• On Thursday, January 15th, Evan Roberts sold 1,810 shares of Phreesia stock. The shares were sold at an average price of $16.38, for a total transaction of $29,647.80.
• On Thursday, January 8th, Evan Roberts sold 6,317 shares of Phreesia stock. The stock was sold at an average price of $17.01, for a total transaction of $107,452.17.

Phreesia Price Performance

Shares of PHR stock traded down $0.63 during trading hours on Tuesday, hitting $15.76. The company’s stock had a trading volume of 888,246 shares, compared to its average volume of 1,011,187. The business has a fifty day moving average of $18.24 and a 200-day moving average of $23.18. The stock has a market cap of $950.23 million, a price-to-earnings ratio of -157.59 and a beta of 0.61. Phreesia, Inc. has a twelve month low of $15.41 and a twelve month high of $32.76. The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.01.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 8th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.11. The firm had revenue of $120.33 million during the quarter, compared to the consensus estimate of $119.98 million. Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.The company’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.25) EPS. As a group, equities research analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current year.

Hedge Funds Weigh In On Phreesia

Hedge funds and other institutional investors have recently modified their holdings of the company. Federated Hermes Inc. acquired a new stake in Phreesia during the 3rd quarter worth approximately $32,000. Asset Management One Co. Ltd. acquired a new stake in shares of Phreesia in the third quarter worth $45,000. State of Alaska Department of Revenue purchased a new position in shares of Phreesia in the 3rd quarter valued at $83,000. Farther Finance Advisors LLC raised its stake in shares of Phreesia by 9,375.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after acquiring an additional 3,000 shares during the period. Finally, Anchor Investment Management LLC acquired a new position in shares of Phreesia during the 3rd quarter valued at $118,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have issued reports on PHR shares. Mizuho decreased their price target on shares of Phreesia from $36.00 to $28.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 10th. KeyCorp cut their price target on Phreesia from $35.00 to $32.00 and set an “overweight” rating for the company in a report on Wednesday, October 8th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Phreesia in a research note on Friday, October 31st. Robert W. Baird decreased their price target on Phreesia from $31.00 to $25.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 10th. Finally, JPMorgan Chase & Co. lowered their price target on Phreesia from $32.00 to $29.00 and set an “overweight” rating for the company in a report on Tuesday, December 9th. Seventeen analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $30.06.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.